Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety extension study comparing GenSci094 and Gonal-f in Chinese women undergoing ART
CTR20240265Phase 3Completed
- Sponsor
- Chengdu Jinkai Biotechnology
- Start
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of corifollitropin alfa in female infertility, sponsored by Chengdu Jinkai Biotechnology. Started Jan 2024; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on CTR20240265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240265.